Both treatment groups were comparable in terms of demographic characteristics, including age and sex distribution, and in their SpO2 at baseline, respiratory rate at baseline, pulse rate, TLC, proportion of patients with serum ferritin level >1000, AST, ALT, proportion of patients with LDH>250, GCS, distribution of different co-morbidities (diabetes and hypertension were identified), distribution of different severity categories of patients (moderate and severe COVID-19), and other co-interventions prescribed. The gene discussed is GPT; the disease is hypertensive disorder.